|
IS
THE SUPPLY OF NONPRESCRIPTION MEDICINES (NPMs) FROM COMMUNITY PHARMACIES
GUIDELINE COMPLIANT?
1Watson
MC, 2Hart J, 1Bond CM, 2Johnston M
1 Department of General Practice and Primary Care
2School of Psychology Department of General Practice and Primary Care,
University of Aberdeen, Westburn Road, Aberdeen, AB25 2AY
m.c.watson@abdn.ac.uk
Introduction
Previous research has shown that many consultations that
result in the supply of NPMs may not comply with the Royal Pharmaceutical
Society of Great Britain (RPSGB) guidelines for the supply of pharmacy
medicines. However, it is not known whether medicine counter assistants (MCAs)
who are involved with most consultations for these drugs, are aware of these
guidelines, nor their attitudes towards them. Furthermore, the mnemonic WWHAM,
has previously been promoted as the "guideline" for MCAs to follow
during consultations, yet there has been little exploration of their attitudes
towards this questioning framework nor the extent of its use in practice. This
multi-faceted study explored the knowledge and attitudes of MCAs towards the
RPSGB guidelines, as well as their use of WWHAM to collect information to inform
their decision to supply NPMs.
Method
This study was approved by NHS Grampian Local Research Ethics Committee. The
study comprised three components: a non-participant observation study; a
self-administered questionnaire; and, semi-structured interviews. Community
pharmacies from Grampian, Scotland were invited to participate. All community
pharmacies registered with the SPPIRe research network and a 2:1 random sample
of non-SPPIRe city: non-city pharmacies were invited to participate. Each MCA
who gave signed consent was observed by a non-pharmacist researcher and
audiotaped for up to one hour. Each audio-taped consultation will be coded by
two independent researchers to determine whether it was compliant with the RPSGB
guidelines and WWHAM mnemonic. A semi-structured, post-consultation interview
was completed following up to three consultations that occurred during this
time. The purpose of each interview was to explore the MCA’s decision-making
process during the consultation. The data collected during the interviews will
also be used to determine whether the customer was known to the MCA, whether
they had previously presented in the pharmacy with a similar product request or
condition/symptom presentation, as this information would be relevant to their
decision-making process but may not have been apparent to the observer. On
completion of the observation period, each MCA was asked to complete a
questionnaire that included questions about their confidence in dealing with
specific NPMs, their knowledge of and attitudes towards the RPSGB guidelines for
the supply of pharmacy medicines, and the mnemonic, WWHAM. Initially, the data
from the three study components will be analysed separately and then combined
for further analysis and triangulation.
Results
Twenty-one pharmacies were recruited to the study. In total, 50 pharmacy support
staff participated in the observation study during which 196 consultations were
observed and audiotaped. Post-consultation interviews were completed for 95
consultations. Completed questionnaires were returned by 45 staff, eight of whom
did not participate in the observation study.
The majority (83%) of consultations were product requests and
most consultations (87%) involved only MCAs. Detailed analysis of the data is
underway and will be available for presentation by March 2005.
Discussion
A summary of the results from the different components of the study will be
presented together with a discussion of some of the ethical issues that arose
during its development and conduct.
Presented at the HSRPP Conference 2005, Reading
|